Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2014
03/26/2014CN103665163A Anti-osteopontin antibody and application thereof
03/26/2014CN103665162A Method for purifying soluble antibody
03/26/2014CN103665161A Method for purification of conjugate of water soluble nano silver particles and mouse-origin IgG monoclonal antibody
03/26/2014CN103665160A Method for purification of conjugate of water soluble nano iron oxide and mouse-origin IgG monoclonal antibody
03/26/2014CN103665159A Method for high-efficiency purification of quantum dot-IgG monoclonal antibody conjugate
03/26/2014CN103665158A Method for preparing endogenous retrovirus polyclonal antibody
03/26/2014CN103665157A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 1C4
03/26/2014CN103665156A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1
03/26/2014CN103665155A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 1F2
03/26/2014CN103665154A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3C4
03/26/2014CN103665153A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 1E1
03/26/2014CN103665152A Canine parvovirus single-domain antibody, and preparation method and application thereof
03/26/2014CN103665151A Preparation method of PCV2Cap protein monoclonal antibody
03/26/2014CN103665149A Schistosoma japonicum katsurada recombinant antigen as well as preparation method and application thereof
03/26/2014CN103665139A Adipocyte fatty-acid binding protein and preparation and application of monoclonal antibody of adipocyte fatty-acid binding protein
03/26/2014CN103665138A Polypeptide, detecting apparatus including same and detecting kit
03/26/2014CN103665113A Human A beta 42 antigenic determinant polypeptide, human A beta 42 antigen, human A beta 42 antibody, application and kit
03/26/2014CN103204925B Synthetic method of general artificial antigen of phthalate plasticizers for immunodetection
03/26/2014CN103102412B Humanized anti-nasopharyngeal-cancer LMP2A extracellular region antibody Fab and application thereof
03/26/2014CN102924577B Chicken high mobility group protein B1 (chHMGB1) antigen polypeptide and anti-chHMGB1 monoclonal antibody
03/26/2014CN102633878B H1-subtype influenza A virus double-antibody sandwich ELISA kit and application
03/26/2014CN102533671B Coxsackie virus A16-type virus strain and applications thereof
03/26/2014CN102178952B Method for extracting human TIG (Tetanus Immune Globulin) based on chromatography
03/26/2014CN102149730B FGF-R4 receptor-specific antagonists
03/26/2014CN101821292B Combination therapy with type I and type II anti-cd20 antibodies
03/25/2014US8680250 Method and device for extracting pollen proteins
03/25/2014US8680249 Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
03/25/2014US8680247 Monoclonal antibodies against glypican-3
03/25/2014US8680246 Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
03/25/2014US8680245 IL-13 binding protein
03/25/2014US8680244 Method for the production of antibodies that bind to multiple membrane spanning proteins
03/25/2014US8680243 Diagnosis and treatment of cancer using anti-GPR49 antibody
03/25/2014US8680242 Plasminogen receptor, polypeptides and antibodies thereof
03/25/2014US8680241 Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof
03/25/2014US8680239 Use of RGM and its modulators
03/25/2014US8680237 Immunoglobulin constant region FC receptor binding agents
03/25/2014US8680055 Methods for decreasing steroidogenesis in prostate cancer cells
03/25/2014US8680046 Inhibitors of viral integrase and methods of use
03/25/2014US8679785 Knobs and holes heteromeric polypeptides
03/25/2014US8679781 In vitro peptide expression library
03/25/2014US8679506 Glucan-based vaccines
03/25/2014US8679503 Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation disease
03/25/2014US8679502 Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same
03/25/2014US8679500 Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases
03/25/2014US8679498 Anti-N3PGLU amyloid beta peptide antibodies and uses thereof
03/25/2014US8679492 Humanized antibodies that bind to CD19 and their uses
03/25/2014US8679491 Method of modulating the activity of functional immune molecules
03/25/2014US8679490 Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
03/25/2014US8679489 Inhibiting cell migration
03/25/2014US8679487 Anti-interleukin-4 receptor antibodies
03/25/2014US8679483 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
03/25/2014CA2676529C Genetically recombinant antibody composition having enhanced effector activity
03/25/2014CA2673592C Methods for the treatment of il-1.beta. related diseases
03/25/2014CA2572618C Taxol immunoassay
03/25/2014CA2565247C Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
03/25/2014CA2537896C East coast fever vaccine based on ctl-specific schizont antigens
03/25/2014CA2524124C Methods for treating cancer using an immunotoxin
03/25/2014CA2520945C Assessing neuronal damage from blood samples
03/25/2014CA2474011C Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
03/25/2014CA2404448C Genes involved in intestinal inflammatory diseases and use thereof
03/25/2014CA2383642C Anthozoa derived chromophores/fluorophores and methods for using the same
03/25/2014CA2379963C Mammalian cytokines; related reagents
03/25/2014CA2306492C Human checkpoint kinase, hcds1, compositions and methods
03/20/2014WO2014043523A1 Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
03/20/2014WO2014043386A1 Clonal lineage antibodies
03/20/2014WO2014043361A1 Fc containing polypeptides with altered glycosylation and reduced effector function
03/20/2014WO2014043223A1 Irhom2 inhibition for the treatment of complement mediated disorders
03/20/2014WO2014042493A1 Novel epitope of ip-10 and antibody to same
03/20/2014WO2014042305A1 Icam-1 antibody and use thereof
03/20/2014WO2014042251A1 Gene knock-in non-human animal
03/20/2014WO2014042226A1 Antigen-specific helper t-cell receptor genes
03/20/2014WO2014042209A1 Peptides that bind to epithelial cell adhesion molecule
03/20/2014WO2014042167A1 Monoclonal antibody against ebag9, hybridoma, and application for monoclonal antibody against ebag9
03/20/2014WO2014041784A1 Ube2t peptides and vaccines containing the same
03/20/2014WO2014041372A1 Lipases, polynucleotides encoding them and their uses
03/20/2014WO2014041069A1 Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof
03/20/2014WO2014040444A1 Method for constructing synonymous codon library of high capacity and optimizing genetic templates
03/20/2014WO2014021693A3 Novel monoclonal antibody which is specifically bound to tm4sf5 protein and use thereof
03/20/2014WO2014016702A3 Humanized forms of monoclonal antibodies to human gnrh receptor
03/20/2014WO2013190292A3 Novel process for preparation of antibody conjugates and novel antibody conjugates
03/20/2014WO2013126746A3 Dll3 modulators and methods of use
03/20/2014WO2013063114A8 Immunobinders directed against tnf
03/20/2014WO2013019906A9 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
03/20/2014US20140081004 Glycosylated specificity exchangers
03/20/2014US20140081003 Methods and compositions for preventing norleucine misincorporation into proteins
03/20/2014US20140081002 Protein complex including bi-specific antibody
03/20/2014US20140081000 Ion Exchange Chromatography with Improved Selectivity for the Separation of Polypeptide Monomers, Aggregates and Fragments by Modulation of the Mobile Phase
03/20/2014US20140080997 Novel mite allergen
03/20/2014US20140080200 Methods of purifying polypeptides
03/20/2014US20140080181 Polynucleotides encoding il-31 monoclonal antibodies
03/20/2014US20140080180 Harvest operations for recombinant proteins
03/20/2014US20140080179 Process for producing protein a-like protein with use of brevibacillus genus bacterium
03/20/2014US20140080152 Compositions and methods for the diagnosis and treatment of tumor
03/20/2014US20140079736 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
03/20/2014US20140079719 IL-17 Antagonistic Antibodies
03/20/2014US20140079715 Human Monoclonal Antibodies Against Hendra and Nipah Viruses
03/20/2014US20140079714 Methods for treating psoriasis
03/20/2014US20140079711 Anti-cd147 antibodies, methods and uses
03/20/2014US20140079709 Immunogenic Composition Comprising Alpha-Hemolysin Oligopeptides
03/20/2014US20140079708 Antibody molecule for human gm-csf receptor alpha
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 1494